In adult dermatomyositis, difficulty swallowing (dysphagia) can persist as a significant clinical challenge even when other treatments have already been tried. A specific therapeutic approach applies to this presentation.
Adult dermatomyositis with difficulty swallowing (dysphagia) that has not responded to other treatments. This pattern of treatment-resistant dysphagia requires a targeted management strategy distinct from standard first-pass approaches.
Intravenous immunoglobulin therapy is among the approaches considered for active disease when dysphagia has proven resistant to other treatments.
IVIG therapy for active disease and dysphagia resistant to other treatments is to be considered.
DOI: 10.1093/rheumatology/keac115
View source ↗